E. Slater

Five years of prospective screening of high-risk individuals from families with familial pancreatic cancer

J. Heverhagen, M. Rothmund, T. Gress, 2009, Gut.

Clinical and genetic analysis of 18 pancreatic carcinoma/melanoma‐prone families

E. Matthäi, N. Habbe, P. Langer, 2010, Clinical genetics.

PALB2 mutations in European familial pancreatic cancer families

K. Strauch, W. Greenhalf, J. Neoptolemos, 2010, Clinical genetics.

Multiple small “imaging” branch-duct type intraductal papillary mucinous neoplasms (IPMNs) in familial pancreatic cancer: indicator for concomitant high grade pancreatic intraepithelial neoplasia?

J. Heverhagen, I. Esposito, T. Gress, 2013, Familial Cancer.

Limited resection of pancreatic cancer in high-risk patients can result in a second primary

D. Bartsch, E. Matthäi, T. Potjer, 2015, Gut.

Multiple small “imaging” branch-duct type intraductal papillary mucinous neoplasms (IPMNs) in familial pancreatic cancer: indicator for concomitant high grade pancreatic intraepithelial neoplasia?

J. Heverhagen, T. Gress, P. Langer, 2012, Familial Cancer.

Increased Myocardial MAO-A, Atrogin-1, and IL-1β Expression in Transgenic Mice with Pancreatic Carcinoma—Benefit of MAO-A Inhibition for Cardiac Cachexia

G. Bonaterra, H. Schwarzbach, E. Slater, 2024, Biomedicines.